Clinical Trial Update: Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating two doses of lemborexant (E2006) on multiple sleep latency in adults with insomnia disorder; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Eisai Inc. | Conditions: Insomnia Disorder | Phase 1 | Status: COMPLETED | Results posted: 2020-01-18